An analysis of current and upcoming industry challenges.
Gunter Jagschies, PhD
Advertisement
Senior Director of strategic customer relations at GE Healthcare BioSciences
Articles by Gunter Jagschies, PhD
Downstream process design can increase facility output through improved overall process yield or higher batch capacity in mass and volume.
Advertisement
Latest Updated Articles
Where is Biopharmaceutical Manufacturing Heading?Published: October 1st 2008 | Updated:
Technical and Economical Evaluation of Downstream Processing Options for Monoclonal Antibody (Mab) ProductionPublished: June 2nd 2006 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
4
Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care
5
